Phenylketonuria, commonly known as PKU, is a rare inherited metabolic disorder. It affects how the body processes an amino acid called phenylalanine. Phenylalanine is found in many protein-rich foods and some artificial sweeteners. In people with PKU, the body cannot break down phenylalanine properly due to a deficiency of the enzyme phenylalanine hydroxylase. This leads to a buildup of phenylalanine in the blood and brain, which can cause serious health problems if untreated.
Causes of Phenylketonuria
Genetic Mutation
PKU is caused by mutations in the PAH gene. This gene provides instructions for making the enzyme phenylalanine hydroxylase. When this enzyme is missing or does not work correctly, phenylalanine accumulates.
Inheritance Pattern
PKU is inherited in an autosomal recessive manner. This means a person must inherit two defective copies of the PAH gene—one from each parent—to have the disorder. Parents who carry one defective gene usually do not have symptoms but can pass the mutation to their children.
What Happens to the Body in PKU?
Phenylalanine Buildup
Without enough functioning enzyme, phenylalanine cannot be converted to tyrosine, another amino acid needed by the body. Instead, phenylalanine builds up in the blood and tissues. High levels are toxic to the brain and nervous system.
Effects on the Brain
Excess phenylalanine disrupts normal brain development. It interferes with the production of neurotransmitters like dopamine and serotonin. This can cause intellectual disability, behavioral problems, and seizures if untreated.
Impact on Other Organs
Though the brain is most affected, high phenylalanine levels can also impact skin and hair pigmentation. This happens because tyrosine, which becomes low in PKU, is necessary for melanin production.
Symptoms and Signs of PKU
Early Symptoms in Infants
Babies with PKU usually appear normal at birth. Symptoms may develop within a few months if untreated, including:
- Vomiting
- Failure to thrive
- Developmental delay
- Hyperactivity
- Seizures
Signs in Older Children and Adults
If PKU is untreated, intellectual disability becomes apparent. Other signs include:
- Learning difficulties
- Behavioral problems such as anxiety and mood swings
- Microcephaly (small head size)
- Light skin, hair, and eye color compared to family members
- Skin conditions like eczema
Diagnosing Phenylketonuria
Newborn Screening
Most countries perform newborn screening to detect PKU early. A small blood sample is taken from the baby’s heel within a few days after birth. Elevated phenylalanine levels indicate the need for further testing.
Confirmatory Tests
Blood tests measure phenylalanine and enzyme activity. Genetic testing can identify mutations in the PAH gene.
Treatment and Management of PKU
Dietary Restrictions
The cornerstone of PKU treatment is a strict low-phenylalanine diet. This limits foods high in protein, such as meat, dairy, nuts, and some grains. Special medical formulas provide protein without phenylalanine. Early and lifelong adherence to this diet prevents brain damage.
Medical Formulas and Supplements
Special amino acid formulas replace natural protein to meet nutritional needs. Supplements may include tyrosine and other vitamins since the diet can be restrictive.
Medications
Sapropterin dihydrochloride is a drug that helps some people with PKU by enhancing enzyme activity. It is not effective for all patients but can help reduce dietary restrictions.
Regular Monitoring
People with PKU require frequent blood tests to monitor phenylalanine levels and adjust diet or treatment. Maintaining safe phenylalanine levels is critical for brain health.
New and Emerging Therapies
Gene therapy and enzyme substitution therapies are under research. These could provide more definitive treatment in the future.
Long-Term Outlook for People with PKU
Normal Life with Early Treatment
When PKU is diagnosed early and treated properly, affected individuals can lead healthy, normal lives. Intellectual development is typically normal, and symptoms are minimal.
Challenges of Late or
Untreated PKU
Delayed treatment can result in permanent intellectual disability and neurological problems. Adults who stopped treatment may experience cognitive decline, mood disorders, and other complications.
Psychosocial Considerations
Living with a strict diet can be challenging socially and emotionally. Support from healthcare providers, family, and patient groups is important.
Preventing Phenylketonuria Complications
Importance of Newborn Screening
Newborn screening has drastically reduced the incidence of severe PKU complications worldwide. Early detection allows immediate treatment initiation.
Lifelong Management
Even adults with PKU benefit from continuing management. Some may need to maintain diet or medication lifelong to prevent neurological symptoms.
Conclusion
Phenylketonuria is a serious metabolic disorder that, without treatment, can cause lasting brain damage and disability. The key to a good outcome is early diagnosis through newborn screening and strict lifelong management of phenylalanine intake. Advances in medical therapies offer hope for improved quality of life in the future. People with PKU can lead healthy, productive lives when properly cared for.
Related topics: